APIs
Slide For More
Sl. | Product Name | Structure | Molecule details | Cas. No. | Remarks/Uses | Specification | Status |
1 | Sitagliptin Phosphate Monohydrate | 
| M.F.:C16H20F6N5O6P | 654671-77-9 | It is a medication to lower blood sugar levels in adults with type 2 diabetes | EP/BP/IP/USP | Commercial |
2 | Dapagliflozin Propanediol | 
| M.F.: C21H25ClO6.C3H8O2.H2O Mol. Wt.: 502.99 | 960404-48-2 | Uses for Type 2 Diabetes Mellitus, Heart Failure, Chronic Kidney Diseases (CKD) Remarks: Effective in lowering HbA1c levels, improving heart and kidney outcomes | USP | Commercial |
3 | Vildagliptin | 
| M.F.:C17H25N3O2 | 274901-16-5 | It is used for the treatment of type II diabetes mellitus in adults. | IP | Commercial |
4 | Tafamidis Meglumine | 
| M.F.: C21H25Cl2NO9 Mol. Wt.: 506.33g/mol | 951395-08-7 | Uses: To treat hereditary ATTR amyloidosis with polyneuropathy, and Transthyretin Amyloid Cardiomyopathy (ATTR-CM). Remarks: Tafamidis Meglumine is the clinically used salt form of Tafamidis, developed for treating transthyretin mediated amyloidosis (ATTR). It's controlled synthesis and high purity are essential to ensure effective TTR stabilization and consistent therapeutic performance. | In-House | Commercial |
5 | Sacubitril-Valsartan Complex | 
| M.F.: C96H120N12Na6O21 Mol. Wt.: 1916.02 | 936623-90-4 | To treat chronic heart failure in adults. | In-House | Commercial |
6 | Sacubitril Sodium | 
| M.F.: C24H28NNaO5 Mol. Wt.: 433.5 | 149690-05-1 | Uses for Heart Failure (with reduced ejection fraction), Potential use in Preserved Ejection Fraction Remarks: Contraindicated with ACE inhibitors-risk of angioedeme increase | In-House | Under Scale-Up |
7 | Midodrine | 
| M.F.: C12H18N2O4 M.Wt.: 254.29 | 42794-76-3 | Uses: Treats symptomatic orthostatic hypotension, and Dialysis-induced Hypotension Remarks: Effective for symptomatic orthostatic hypotension and also often used in neurological conditions with autonomic failure | In-House/USP | Under Development |
8 | Midodrine Hydrochloride | 
| M.F.: C12H18N2O4.HCl M.Wt.: 290.75 | 3092-17-9 | Uses: Symptomatic Orthostatic Hypotension, Dialysis-induced hypotension and in spinal cord injury Remarks: Improves standing blood pressure, reduces dizziness, fatigue and syncope | In-House/USP | Under Development |
